Data collection is paused while the tracker is being upgraded. The data below is complete up to 20 August 2026.

Nextech Invest

Switzerland · 64 portfolio companies

Portfolio

CompanySectorStageCountry
A2 Biotherapeutics
ARS Pharmaceuticals | Silverback Therapeutics Biotech
AiRNA
Alpha-9 Oncology
Alterome Therapeutics
Alumis Biotech
Ambagon Therapeutics
Ambrx Biopharma
Arrakis Therapeutics Biotech
Arvinas
Atavistik Bio
Attovia Therapeutics
Autolus Therapeutics plc
Be Biopharma
Black Diamond Therapeutics, Inc
Blueprint Medicines
Boundless Bio
C4 Therapeutics
CARGO Therapeutics
Circle Pharma
Cleave Biosciences
Context Therapeutics
Cullinan Therapeutics
Delphia Therapeutics
EQRx | Revolution Medicines Healthtech
Exo Therapeutics
Flare Therapeutics
Hexagon Bio
IDRx
ITM
IconOVir Bio
Ideaya Biosciences
Jounce Therapeutics
K36 Therapeutics
Khartis Therapeutics
Kinnate Biopharma
Kronos Bio
Kura Oncology, Inc.
Kymera Therapeutics
Laronde Bio
MOMA Therapeutics
Mariana Oncology
Mersana Therapeutics
Mirati Therapeutics
Neon Therapeutics
ORIC Pharmaceuticals
PMV Pharma
Parabilis Medicines
Peloton Therapeutics
ProfoundBio HealthtechChina
Relay Therapeutics
Sail Biomedicines United States
Scorpion Therapeutics
Sesame Therapeutics
Silence Therapeutics
Synnovation Therapeutics
TYRA Biosciences
Tango Therapeutics
Theseus Pharmaceuticals
Tubulis BiotechGermany
Turning Point Therapeutics, Inc.
Vividion Therapeutics Healthtech
Zenith Therapeutics
Zymeworks

Recorded changes

No recorded changes.

Spotted something wrong? Tell us.